+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Hemostats & Tissue Sealants Market by Product Type, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4904516
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Hemostats & Tissue Sealants Market grew from USD 10.50 billion in 2023 to USD 11.78 billion in 2024. It is expected to continue growing at a CAGR of 12.33%, reaching USD 23.72 billion by 2030.

The global market for hemostats and tissue sealants is defined by products designed to achieve hemostasis and close wounds during surgical procedures. These applications are critical, as they facilitate the control of bleeding and improve clinical outcomes in surgeries across various specialties, including cardiovascular, neurological, orthopedic, and general surgeries. The necessity for these products is underscored by the rising number of surgical procedures worldwide, increasing awareness about blood loss management, and technological advancements in surgical materials. Key end-use segments include hospitals, ambulatory surgical centers, and clinics. Among critical growth factors, the prevalence of chronic diseases necessitating surgery, aging population, and advancements in medical technology play significant roles. Recent opportunities lie in expanding markets such as East Asia, where increased healthcare spending and better access to surgical care drive demand. Companies are encouraged to invest in R&D for developing advanced products with improved efficacy, such as bio-compatible and synthetic sealants. Nevertheless, the market faces challenges, including stringent regulatory requirements, high costs associated with advanced products, and potential side effects. The market's competitive nature further intensifies these challenges, requiring continuous innovation and maintaining product differentiation. The best areas for innovation include developing cost-effective, easy-to-use products for minimally invasive surgeries and enhancing product safety profiles to minimize adverse reactions. Explorations into bio-degradable options and combinations with antimicrobial agents could also push growth. Companies can leverage collaborative partnerships with research institutions to access new technologies and obtain a competitive edge. While the market holds promising opportunities, successfully capitalizing on them necessitates addressing regulatory hurdles and cost constraints through strategic pricing and product development approaches.

Understanding Market Dynamics in the Hemostats & Tissue Sealants Market

The Hemostats & Tissue Sealants Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Prevalence of chronic disorders and need for timely surgeries
    • Rise of biopolymer-based disposable hemostats
    • Availability of hemostats through trusted online medical device channels
  • Market Restraints
    • Low outlining quality and high costs of surgical sealants
  • Market Opportunities
    • Introduction of new-generation tissue sealants and hemostatic agents
    • Initiatives focusing on wound healing and closure management
  • Market Challenges
    • Strict standards regarding the utilization of hemostats & tissue sealants

Exploring Porter’s Five Forces for the Hemostats & Tissue Sealants Market

Porter’s Five Forces framework further strengthens the insights of the Hemostats & Tissue Sealants Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Hemostats & Tissue Sealants Market

External macro-environmental factors deeply influence the performance of the Hemostats & Tissue Sealants Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Hemostats & Tissue Sealants Market

The Hemostats & Tissue Sealants Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Hemostats & Tissue Sealants Market

The Hemostats & Tissue Sealants Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Hemostats & Tissue Sealants Market

The Hemostats & Tissue Sealants Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Hemostats & Tissue Sealants Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Advanced Medical Solutions Group PLC, Aegis Lifesciences Private Limited., B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Cardinal Health, Inc., CooperSurgical, Inc., CryoLife, Inc., CSL Behring, CuraMedical B.V., Grifols, S.A., Hemostasis, LLC, Hologic, Inc., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., KAKEN PHARMACEUTICAL CO., LTD., KATSAN Katgüt Sanayi ve Tic. A.Ş., Medline Industries, LP., Medtronic PLC, Olympus Corporation, Owens & Minor, Pfizer, Inc., Smith & Nephew PLC, Stryker Corporation, Teleflex Incorporated, Terumo Corporation, Thermo Fisher Scientific Inc., Vivostat A/S, and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Hemostats & Tissue Sealants Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product Type
    • Hemostats
      • Active Hemostats
      • Flowable Hemostats
      • Mechanical Hemostats
    • Tissue sealants
      • Fibrin Sealants
      • Synthetic Sealants
  • Application
    • Burn & Trauma Cases
    • Cardiovascular
    • General Surgeries
    • Neurological
    • Orthopedic
    • Reconstructive Surgeries
    • Urological
  • End User
    • Ambulatory Surgical Centers
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of chronic disorders and need for timely surgeries
5.1.1.2. Rise of biopolymer-based disposable hemostats
5.1.1.3. Availability of hemostats through trusted online medical device channels
5.1.2. Restraints
5.1.2.1. Low outlining quality and high costs of surgical sealants
5.1.3. Opportunities
5.1.3.1. Introduction of new-generation tissue sealants and hemostatic agents
5.1.3.2. Initiatives focusing on wound healing and closure management
5.1.4. Challenges
5.1.4.1. Strict standards regarding the utilization of hemostats & tissue sealants
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Hemostats & Tissue Sealants Market, by Product Type
6.1. Introduction
6.2. Hemostats
6.2.1. Active Hemostats
6.2.2. Flowable Hemostats
6.2.3. Mechanical Hemostats
6.3. Tissue sealants
6.3.1. Fibrin Sealants
6.3.2. Synthetic Sealants
7. Hemostats & Tissue Sealants Market, by Application
7.1. Introduction
7.2. Burn & Trauma Cases
7.3. Cardiovascular
7.4. General Surgeries
7.5. Neurological
7.6. Orthopedic
7.7. Reconstructive Surgeries
7.8. Urological
8. Hemostats & Tissue Sealants Market, by End User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Hospitals
8.4. Specialty Clinics
9. Americas Hemostats & Tissue Sealants Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Hemostats & Tissue Sealants Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Hemostats & Tissue Sealants Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Olympus Launches EndoClot Hemostatic Agents and Submucosal Injection Agent in European Markets
12.3.2. Corza Medical Signs Definitive Agreement to Acquire Takeda's TachoSil Manufacturing Operations
12.3.3. Advamedica Inc Announces FDA Clearance for Ax-Surgi Surgical Hemostat
12.3.4. Team Develops Extracellular Matrix-Based Sticky Sealants For Corneal Tissue Reconstruction
12.3.5. Medcura Receives Breakthrough Device Designation for its LifeGel™ Absorbable Surgical Hemostat
12.3.6. Cresilon Closes $25 Million in Series A-4 Financing to Accelerate Global Expansion and Bring Revolutionary Hemostatic Gel to Human Health Market
12.3.7. ZEISS Receives FDA Clearance for MTLawton - A New Generation of Bipolar Forceps for Electrosurgery
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. HEMOSTATS & TISSUE SEALANTS MARKET RESEARCH PROCESS
FIGURE 2. HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. HEMOSTATS & TISSUE SEALANTS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. HEMOSTATS & TISSUE SEALANTS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. HEMOSTATS & TISSUE SEALANTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. HEMOSTATS & TISSUE SEALANTS MARKET DYNAMICS
TABLE 7. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY ACTIVE HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY FLOWABLE HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MECHANICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY FIBRIN SEALANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC SEALANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY BURN & TRAUMA CASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY GENERAL SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY RECONSTRUCTIVE SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY UROLOGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 46. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 47. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 48. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 51. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 52. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 53. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 74. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 75. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 79. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 80. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 89. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 90. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 119. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 120. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 133. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 135. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 136. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 140. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 141. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 145. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 146. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 150. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 151. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 155. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 156. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 165. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 166. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. NIGERIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. NORWAY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. NORWAY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 180. NORWAY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 181. NORWAY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. NORWAY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. POLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. POLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 185. POLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 186. POLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. POLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. QATAR HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. QATAR HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 190. QATAR HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 191. QATAR HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. QATAR HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. SPAIN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. SPAIN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 210. SPAIN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 211. SPAIN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. SPAIN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. TURKEY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. TURKEY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 225. TURKEY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 226. TURKEY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. TURKEY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. HEMOSTATS & TISSUE SEALANTS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 239. HEMOSTATS & TISSUE SEALANTS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Hemostats & Tissue Sealants Market, which are profiled in this report, include:
  • Abbott Laboratories
  • Advanced Medical Solutions Group PLC
  • Aegis Lifesciences Private Limited.
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • CooperSurgical, Inc.
  • CryoLife, Inc.
  • CSL Behring
  • CuraMedical B.V.
  • Grifols, S.A.
  • Hemostasis, LLC
  • Hologic, Inc.
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • KAKEN PHARMACEUTICAL CO., LTD.
  • KATSAN Katgüt Sanayi ve Tic. A.Ş.
  • Medline Industries, LP.
  • Medtronic PLC
  • Olympus Corporation
  • Owens & Minor
  • Pfizer, Inc.
  • Smith & Nephew PLC
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
  • Vivostat A/S
  • Zimmer Biomet

Methodology

Loading
LOADING...

Table Information